Ghassemi, Saba http://orcid.org/0000-0002-2415-3576
Durgin, Joseph S.
Nunez-Cruz, Selene
Patel, Jai
Leferovich, John
Pinzone, Marilia
Shen, Feng
Cummins, Katherine D. http://orcid.org/0000-0001-9041-0828
Plesa, Gabriela http://orcid.org/0000-0002-4279-5943
Cantu, Vito Adrian
Reddy, Shantan
Bushman, Frederic D.
Gill, Saar I.
O’Doherty, Una
O’Connor, Roddy S. http://orcid.org/0000-0001-5645-4544
Milone, Michael C. http://orcid.org/0000-0002-1580-9844
Funding for this research was provided by:
St. Baldrick’s Foundation
AABB | National Blood Foundation
U.S. Department of Defense (W81XWH-20-1-0417)
U.S. Department of Health & Human Services | NIH | Center for Scientific Review (RO1CA226983)
Novartis Pharmaceuticals Corporation
Article History
Received: 10 April 2021
Accepted: 17 December 2021
First Online: 21 February 2022
Competing interests
: M.C.M. is an inventor on patent applications related to CAR technology (US patents 9,481,728 and 9,499,629 B2) and has received licencing royalties from the Novartis corporation. S.G. and M.C.M. are inventors on a patent application related to methods of manufacturing non-activated CAR T cells (provisional patent PCT/US2020/027734). The other authors declare no competing interests.
Free to read: This content has been made available to all.